Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Read More…
Industry, Sector and Symbol
Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Phone615-234-5900
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.77 billion
Profitability
Miscellaneous
Employees11,000
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable
Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions
What is Surgery Partners' stock symbol?
Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."
How will Surgery Partners' stock buyback program work?
Surgery Partners announced that its board has authorized a stock buyback program on Saturday, December 16th 2017, which permits the company to repurchase $50,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company's board believes its shares are undervalued.
How were Surgery Partners' earnings last quarter?
Surgery Partners Inc (NASDAQ:SGRY) released its quarterly earnings data on Wednesday, August, 7th. The company reported ($0.35) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.13. The company earned $445.40 million during the quarter, compared to the consensus estimate of $450.89 million. Surgery Partners had a negative return on equity of 4.65% and a negative net margin of 11.61%. The company's quarterly revenue was up 2.0% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.57) EPS. View Surgery Partners' Earnings History.
When is Surgery Partners' next earnings date?
What price target have analysts set for SGRY?
2 equities research analysts have issued 1 year price targets for Surgery Partners' stock. Their forecasts range from $12.00 to $15.00. On average, they anticipate Surgery Partners' stock price to reach $13.50 in the next twelve months. This suggests a possible upside of 74.6% from the stock's current price. View Analyst Price Targets for Surgery Partners.
What is the consensus analysts' recommendation for Surgery Partners?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Surgery Partners.
Has Surgery Partners been receiving favorable news coverage?
News headlines about SGRY stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Surgery Partners earned a daily sentiment score of -2.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Surgery Partners.
Are investors shorting Surgery Partners?
Surgery Partners saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 5,717,800 shares, an increase of 6.9% from the July 31st total of 5,349,000 shares. Based on an average trading volume of 412,100 shares, the days-to-cover ratio is presently 13.9 days. Currently, 27.9% of the company's shares are short sold. View Surgery Partners' Current Options Chain.
Who are some of Surgery Partners' key competitors?
What other stocks do shareholders of Surgery Partners own?
Who are Surgery Partners' key executives?
Surgery Partners' management team includes the folowing people:
- Mr. Wayne Scott DeVeydt, CEO & Director (Age 49)
- Mr. Thomas Francis Cowhey, Exec. VP, CFO & Principal Accounting Officer (Age 47)
- Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 48)
- Dr. Angela Justice Ph.D., Exec. VP & Chief HR Officer (Age 46)
- Mr. George M. Goodwin, Pres of American Group (Age 58)
Who are Surgery Partners' major shareholders?
Surgery Partners' stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.55%), BlackRock Inc. (3.47%), AMI Asset Management Corp (1.89%), Pictet Asset Management Ltd. (1.32%), Pictet Asset Management Ltd. (1.32%) and Citadel Advisors LLC (1.10%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Brandan Lingle, Jason Eric Evans and Teresa Deluca. View Institutional Ownership Trends for Surgery Partners.
Which institutional investors are selling Surgery Partners stock?
SGRY stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., JPMorgan Chase & Co., Pictet Asset Management Ltd., Pictet Asset Management Ltd., Wells Fargo & Company MN, Bank of America Corp DE, Parametric Portfolio Associates LLC and Cubist Systematic Strategies LLC. View Insider Buying and Selling for Surgery Partners.
Which institutional investors are buying Surgery Partners stock?
SGRY stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., AMI Asset Management Corp, Marshall Wace LLP, Citadel Advisors LLC, Dimension Capital Management LLC, Charles Schwab Investment Management Inc. and Strs Ohio. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans and Teresa Deluca. View Insider Buying and Selling for Surgery Partners.
How do I buy shares of Surgery Partners?
Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Surgery Partners' stock price today?
One share of SGRY stock can currently be purchased for approximately $7.73.
How big of a company is Surgery Partners?
Surgery Partners has a market capitalization of $382.48 million and generates $1.77 billion in revenue each year. The company earns $-205,710,000.00 in net income (profit) each year or ($2.45) on an earnings per share basis. Surgery Partners employs 11,000 workers across the globe.View Additional Information About Surgery Partners.
What is Surgery Partners' official website?
How can I contact Surgery Partners?
Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]
MarketBeat Community Rating for Surgery Partners (NASDAQ SGRY)
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
